Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Q3 2025 value amounting to 0.92.

  • Ironwood Pharmaceuticals' Asset Utilization Ratio fell 482.81% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year decrease of 482.81%. This contributed to the annual value of 0.86 for FY2024, which is 5175.68% up from last year.
  • Ironwood Pharmaceuticals' Asset Utilization Ratio amounted to 0.92 in Q3 2025, which was down 482.81% from 0.92 recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Asset Utilization Ratio peaked at 0.96 during Q3 2024, and registered a low of 0.37 during Q1 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' median Asset Utilization Ratio value was 0.69 (recorded in 2021), while the average stood at 0.66.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Asset Utilization Ratio plummeted by 5355.77% in 2021, and later surged by 14579.31% in 2024.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Asset Utilization Ratio stood at 0.38 in 2021, then grew by 2.27% to 0.38 in 2022, then surged by 131.97% to 0.89 in 2023, then rose by 6.68% to 0.95 in 2024, then fell by 3.35% to 0.92 in 2025.
  • Its Asset Utilization Ratio stands at 0.92 for Q3 2025, versus 0.92 for Q2 2025 and 0.94 for Q1 2025.